National Hemophilia Foundation Judith Graham Pool Postdoctoral Research Fellowships
NHF’s premier research fellowship program is named in honor of Dr. Judith Graham Pool. Established by NHF in 1972, the Judith Graham Pool (JGP) Postdoctoral Research Fellowships have provided a long legacy of support for basic science and pre-clinical research in bleeding disorders. In 1965, Dr. Pool discovered a method of extracting clotting factor from human plasma to formulate cryoprecipitate. This breakthrough opened the door to a series of research developments that would revolutionize treatment for hemophilia and ultimately lead to its management through recombinant replacement factor and current extended half-life therapies.
Candidates for the JGP Postdoctoral Research Fellowship must have completed doctoral training and apply for the JGP fellowship award from a doctoral, postdoctoral, internship or residency training program. Individuals with more than six years of experience since completing doctoral training are not eligible to apply. Established investigators or faculty members are also not eligible.
U.S. citizenship is not required, but prospective candidates must be affiliated with a U.S.-based organization (such as a university, college, hospital, government agency and/or lab). Only investigators associated with a non-commercial institution will be eligible for NHF grant funding.
The JGP fellowship recipient will be expected to spend at least 80% of their working time on the funded research project. The remaining 20% may be devoted to teaching and/or other clinical/research work at their institution. The JGP award recipient and his/her mentor(s) are expected to remain with their institution for the duration of the project being funded. Letters of support signed by appropriate officials of the institution will be required as part of the application.
Scope of Research
Permissible proposal topics include pre-clinical or basic science research on the biochemical, genetic or hematologic aspects of hemophilia, von Willebrand disease, or other inherited bleeding disorder. Other topics might include focus on hepatitis/liver disease, HIV/AIDS, joint disease/orthopedics, women’s health, or other therapeutic modalities pertaining to bleeding disorders.
NHF encourages all interested and eligible candidates to submit a ‘JGP Letter of Intent’ by no later than 5:00 pm Eastern time, Tuesday, February 9, 2016. All letters will be evaluated by members of NHF’s Research Review Committee.
For more detailed information about how to submit a JGP LOI, please access the last PDF file document listed in the chart below.
This opportunity has expired. It was originally published here: